Orexo AB | Key People and Executives
Henrik Kjaer Hansen
Director
Alf Gunnar Martin Nicklasson
Chairman
Kirsten Detrick
Independent Director
David Colpman
Independent Director
Maria Christina Paulsdotter Schauman
Independent Director
Raymond George Hill
Independent Director
Staffan Lindstrand
Independent Director
Nikolaj Sørensen
President & Chief Executive Officer
Jesper Lind
Chief Operating Officer
Henrik Neilsen Juuel
Chief Financial Officer & Executive Vice President
Michael Sumner
Chief Medical Officer
Henrik Kjaer Hansen
Director
Christina Astrén Eriksson
Head-Investor Relations & Communications
Lena Wange
Manager-Communications & Investor Relations
Lina Johansson
Manager-Human Resources
Alf Gunnar Martin Nicklasson
Chairman
Kirsten Detrick
Independent Director
David Colpman
Independent Director
Maria Christina Schauman
Independent Director
Raymond George Hill
Independent Director
Staffan Lindstrand
Independent Director
| Address |
Rapsgatan 7e
Uppsala UP 751 05
Sweden
|
|
Employees
|
- |
| Website |
http://www.orexo.com |
| Updated |
07/08/2019 |
| Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. Its focuses on the treatment of opioid dependence. Its pipeline comprises of Zubsolv, Abstral, Edluar, Zubsolv, OX51, OX-MP1, and OX382. |
